Musculoskeletal · PANCE / PANRE

Osteoarthritis (OA)

Non-inflammatory degenerative joint disease driven by progressive articular cartilage loss.

Also known as: OA, degenerative joint disease, DJD, osteoarthrosis

Overview

Chronic degenerative joint disease characterized by progressive loss of articular cartilage, subchondral bone remodeling, osteophyte formation, and mild synovitis. Most commonly affects weight-bearing joints (knee, hip), the hand DIP/PIP and first CMC joints, and the cervical and lumbar spine.

Epidemiology

Most prevalent form of arthritis worldwide. Prevalence rises sharply after age 50; women > men after menopause. Symptomatic knee OA affects ~10% of US adults over 60.

Try two board-style Osteoarthritis questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1MusculoskeletalMedium
A 68-year-old woman reports several months of right knee and bilateral hand pain that worsens with activity and improves with rest. Morning stiffness lasts about 10 minutes. Exam shows bony enlargement at the distal interphalangeal joints and crepitus of the right knee without warmth or effusion. Radiographs show asymmetric joint-space narrowing, marginal osteophytes, and subchondral sclerosis. Inflammatory markers are normal. Which of the following is the most appropriate first-line pharmacologic treatment?
  • AOral duloxetine
  • BTopical diclofenac
  • CGlucosamine sulfate
  • DOral prednisone
Reveal answer & full explanation
Correct answer: B — Topical diclofenac
  • AOral duloxetine
  • BTopical diclofenac
  • CGlucosamine sulfate
  • DOral prednisone

Why Topical diclofenac is correct

  • This presentation is osteoarthritis, a degenerative joint disease distinguished from inflammatory arthritis by activity-related pain, brief morning stiffness (under 30 minutes), bony rather than soft-tissue swelling, normal inflammatory markers, and the classic radiographic tetrad of asymmetric joint-space narrowing, osteophytes, subchondral sclerosis, and cysts
  • First-line pharmacotherapy per ACR/OARSI guidance is a topical NSAID such as diclofenac, favored for knee and hand OA because it provides analgesia with minimal systemic exposure
  • Oral NSAIDs and duloxetine are added when needed; intra-articular corticosteroids treat acute flares

Why the others are wrong

  • Oral duloxetine — conditionally recommended for knee osteoarthritis, but ACR places it after topical and oral NSAIDs rather than as initial therapy, and it has little role in hand OA
  • Glucosamine sulfate — ACR strongly recommends against glucosamine for hand, hip, and knee osteoarthritis because trials show no benefit over placebo
  • Oral prednisone — used for systemic inflammatory and autoimmune arthritis; systemic steroids are not indicated for osteoarthritis and carry unnecessary metabolic risk

Additional high-yield points

  • The key misconception these distractors target is escalating to a systemic or unproven agent before trying the topical NSAID that guidelines place first
Question 2MusculoskeletalMedium
A 6-year-old boy is brought to the emergency department after falling from monkey bars onto an outstretched hand. He holds the right elbow slightly flexed and refuses to move it. There is marked swelling about the distal humerus with no skin tenting or laceration. The radial pulse is palpable, the hand is warm and pink, and capillary refill is 2 seconds. He is unable to flex the interphalangeal joint of the thumb or the distal interphalangeal joint of the index finger, and sensation is intact throughout the hand. A lateral radiograph shows the distal humeral fragment displaced posteriorly with no cortical contact between the fragments. Which of the following is the most appropriate next step in management?
  • AClosed reduction with percutaneous pinning
  • BLong-arm splint and outpatient follow-up
  • COpen reduction with internal fixation
  • DClosed reduction and long-arm casting
  • ESurgical exploration of the median nerve
Reveal answer & full explanation
Correct answer: A — Closed reduction with percutaneous pinning
  • AClosed reduction with percutaneous pinning
  • BLong-arm splint and outpatient follow-up
  • COpen reduction with internal fixation
  • DClosed reduction and long-arm casting
  • ESurgical exploration of the median nerve

Why Closed reduction with percutaneous pinning is correct

  • A fall onto an outstretched hand in a child of this age, with swelling at the distal humerus and posterior displacement of the distal fragment, describes an extension-type supracondylar humerus fracture, the most common elbow fracture in children.
  • Loss of all cortical contact makes this a Gartland type III injury. Completely displaced fractures are unstable and cannot be held by a cast, so the standard of care is closed reduction under anesthesia with percutaneous Kirschner wire fixation, generally the same day or within 24 hours.
  • A poorly perfused or white hand, an open fracture, or signs of compartment syndrome are what make the operation emergent rather than urgent. None of those is present here.
  • Inability to flex the thumb interphalangeal joint and the index distal interphalangeal joint with sensation fully intact is an isolated anterior interosseous nerve palsy, the classic neurologic finding with this fracture. The anterior interosseous nerve is a motor branch of the median nerve with no cutaneous sensory distribution, the injury is a neurapraxia in the great majority of cases, and it recovers spontaneously over weeks to months.
  • That palsy does not change the operation: the fracture is reduced and pinned, and the nerve is observed.

Why the others are wrong

  • Long-arm splint and outpatient follow-up — a splint is applied in the emergency department for comfort while the child awaits the operating room, but discharging him in it makes splinting the definitive treatment, which belongs to a nondisplaced Gartland type I fracture. A completely displaced fracture sent home unreduced risks malunion into cubitus varus (the trap is treating every pediatric elbow fracture as a splint-and-refer problem).
  • Open reduction with internal fixation — reserved for fractures that cannot be reduced closed, open fractures, and limbs requiring vascular exploration. Going open first adds soft-tissue injury, stiffness, and scarring to an injury that almost always reduces closed (the trap is reaching for open fixation simply because the fracture is completely displaced).
  • Closed reduction and long-arm casting — the reduction is the easy part; holding it is not. Without pins a completely displaced fracture redisplaces in the cast, and the elbow flexion needed to hold it compromises an already swollen limb (the trap is stopping one step short of definitive fixation).
  • Surgical exploration of the median nerve — an isolated anterior interosseous palsy accompanying a displaced supracondylar fracture is a traction neurapraxia that is observed, not explored. Exploration is considered only for a deficit that appears after manipulation with entrapment suspected, or for failure to recover over months (the trap is treating any motor deficit as a surgical emergency).

Additional high-yield points

  • Document the radial pulse, capillary refill, and the median, radial, and ulnar nerves before and after any manipulation. Test the median nerve's anterior interosseous branch with the OK sign, the radial nerve with wrist and thumb extension, and the ulnar nerve with finger abduction.
  • A pulseless white hand demands emergent reduction and pinning first, with open exploration of the brachial artery only if perfusion is not restored by the reduction. A hand that remains pulseless but warm, pink, and well perfused afterward is observed in hospital with serial perfusion checks over 24 to 48 hours.
  • The feared complication is Volkmann ischemic contracture from a missed forearm compartment syndrome. Pain out of proportion and pain on passive finger extension are the warning signs.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Osteoarthritis (OA) outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Age >50
  • Female sex (especially hand and knee OA)
  • Obesity (knee, hip)
  • Prior joint injury, surgery, or intra-articular fracture (post-traumatic OA)
  • Repetitive occupational or athletic loading
  • Genetic predisposition (familial hand OA)
  • Joint malalignment (varus/valgus), congenital hip dysplasia
  • Metabolic/endocrine: hemochromatosis, acromegaly, alkaptonuria (secondary OA)

Pathophysiology

Imbalance between cartilage matrix synthesis and degradation, driven by matrix metalloproteinases and pro-inflammatory cytokines (IL-1, TNF). Cartilage softens, fibrillates, and erodes. The underlying subchondral bone responds with sclerosis, cyst formation, and marginal osteophytes. Low-grade synovial inflammation contributes to pain but is qualitatively different from autoimmune arthritis.

Clinical presentation

Symptoms

  • Insidious joint pain worse with activity and improved by rest
  • Brief morning stiffness (<30 minutes) and gel phenomenon after inactivity
  • Reduced range of motion, crepitus, functional limitation
  • Knee: medial joint-line pain, buckling, difficulty with stairs
  • Hip: groin pain referred to thigh or buttock, limp
  • Hand: pain and bony enlargement at DIP (Heberden) and PIP (Bouchard) nodes; first CMC squaring

Signs / physical exam

  • Bony enlargement, crepitus, tenderness at joint line
  • Cool joint without significant warmth or erythema
  • Restricted ROM, antalgic gait
  • Mild effusion possible but lacking the boggy synovitis of RA

Classic findings

Heberden nodes (DIP) and Bouchard nodes (PIP); squared first CMC joint; medial knee joint-line tenderness.

Differential diagnosis

  • Rheumatoid arthritis — Symmetric MCP/PIP/wrist involvement, prolonged morning stiffness (>1 h), constitutional symptoms, positive RF/anti-CCP, elevated ESR/CRP
  • Psoriatic arthritis — DIP involvement with psoriasis or nail pitting, dactylitis, enthesitis; can mimic hand OA
  • Gout / pseudogout — Acute monoarticular attacks with warmth and erythema; crystals on arthrocentesis
  • Septic arthritis — Acute monoarticular pain with fever and effusion; arthrocentesis with WBC >50,000 mandatory to exclude
  • Hemochromatosis arthropathy — MCP 2/3 involvement (handshake sign), hook-like osteophytes, elevated ferritin/transferrin saturation
  • Avascular necrosis (hip) — Groin pain with restricted internal rotation; crescent sign on plain film; MRI sensitive
  • Bursitis / tendinopathy — Periarticular tenderness without true joint-line pain; preserved passive ROM

Diagnostic workup

Diagnostic criteria

ACR clinical criteria for knee OA: knee pain plus at least 3 of: age >50, stiffness <30 min, crepitus, bony tenderness, bony enlargement, no palpable warmth. Radiographic hallmarks (Kellgren-Lawrence): joint-space narrowing, subchondral sclerosis, subchondral cysts, marginal osteophytes.

Labs

  • Generally not required for diagnosis when classic clinical and radiographic features present
  • ESR, CRP, RF, anti-CCP, ANA only if inflammatory arthritis suspected (should be normal or negative in OA)
  • Arthrocentesis only when effusion present and inflammatory or septic process must be excluded — OA fluid is non-inflammatory (WBC <2000, clear/straw-colored)

Imaging

  • Weight-bearing plain radiographs of the affected joint — first-line
  • MRI reserved for atypical presentations, suspected meniscal or ligamentous injury, or possible avascular necrosis
  • Ultrasound can detect effusion and osteophytes but is not routinely needed

Diagnostic algorithm

FeatureOsteoarthritisRheumatoid arthritis
OnsetInsidious, older ageSubacute, 30-50 yo (any age)
Joint patternDIP, PIP, 1st CMC, knees, hips, spineMCP, PIP, wrists; symmetric
Morning stiffness<30 min>1 hour
Symptom patternWorse with activity, better with restBetter with activity, worse after rest
Systemic symptomsAbsentFatigue, low-grade fever, weight loss
Inflammatory markersNormalElevated ESR/CRP
SerologyNegativeRF and/or anti-CCP often positive
Synovial fluid WBC<2000 (non-inflammatory)2000-50,000 (inflammatory)
RadiographsJoint-space narrowing, osteophytes, subchondral sclerosisPeriarticular osteopenia, marginal erosions, symmetric joint-space loss
Comparison of osteoarthritis vs rheumatoid arthritis — the highest-yield differentiation on PANCE.

Treatment

First-line

  • Patient education and self-management programs
  • Exercise: low-impact aerobic, strengthening (quadriceps for knee OA), aquatic therapy
  • Weight loss (5-10% body weight) for knee or hip OA in overweight patients
  • Topical NSAIDs (diclofenac gel) — preferred initial pharmacotherapy for hand and knee OA
  • Acetaminophen up to 3 g/day (modest benefit, useful when NSAIDs contraindicated)
  • Oral NSAIDs — ibuprofen, naproxen, meloxicam (lowest effective dose, shortest duration; add PPI if GI risk)

Second-line / adjunct

  • Intra-articular corticosteroid injection (triamcinolone, methylprednisolone) — short-term relief for flares; limit to 3-4 per joint per year
  • Duloxetine — adjunct for chronic knee OA pain, particularly with comorbid depression or widespread pain
  • Topical capsaicin — adjunct for hand or knee OA
  • Tramadol — limited role; reserve for patients who cannot tolerate NSAIDs and have failed other measures
  • Intra-articular hyaluronic acid — conditional, not recommended by 2019 ACR for knee or hip
  • Avoid chronic opioids — no long-term benefit and substantial harm

Complications

  • Progressive functional decline, falls
  • Sleep disturbance, depression, chronic opioid exposure (iatrogenic)
  • Secondary muscle atrophy and deconditioning
  • Joint deformity (varus knee, fixed flexion of hip)
  • Perioperative complications of arthroplasty: infection, DVT/PE, periprosthetic fracture

PANCE pearls

  • Morning stiffness <30 minutes and pain that worsens through the day with activity favor OA over RA.
  • First CMC squaring and Heberden/Bouchard nodes are pathognomonic for primary hand OA.
  • ACR conditionally recommends AGAINST glucosamine, chondroitin, hydroxychloroquine, methotrexate, TNF inhibitors, and stem cell injections for OA.
  • If a patient with presumed OA develops a hot, swollen joint, perform arthrocentesis — superimposed gout, pseudogout, or septic arthritis can occur.

References

  • ACR/AF 2019 — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (Kolasinski et al., Arthritis Care Res 2020)
  • OARSI 2019 — OARSI Guidelines for the Non-Surgical Management of Knee, Hip, and Polyarticular Osteoarthritis (Bannuru et al., Osteoarthritis Cartilage 2019)
  • AAOS 2021 — AAOS Clinical Practice Guideline: Management of Osteoarthritis of the Knee (Non-Arthroplasty), 3rd ed.

Practice Musculoskeletal questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.